OKOlgun Keskin

Olgun Keskin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olgun Keskin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Do serum glucose and HbA1c levels predict mortality in patients with diabetes mellitus hospitalised for community-acquired pneumonia: Serum glucose and HbA1c levels and pneumonia-associated mortality in diabetes mellitus

    by Işılay Kalan Sarı, Olgun Keskin, Ayşegül Seremet Keskin

    Respiratory tract infections, which are among the most common infections, can be serious and fatal in patients with diabetes mellitus (DM). Studies show that community-acquired pneumonia (CAP) is more severe in people with DM. However, the impact of serum glucose and HbA1c levels on mortality associated with pneumonia remains controversial. We designed this study to investigate the impact of DM on the prognosis of pneumonia and to elucidate the relationship between glycaemic parameters and mortality in CAP. The study included a retrospective analysis of patients with CAP treated in the Chest Diseases Department and Intensive Care Unit (ICU) of Antalya Research and Training Hospital between January 2022 and June 2025. Patient demographics, clinical and laboratory parameters and clinical outcomes were analysed. The mortality rate of patients with DM was significantly higher than that of patients without DM ( p = 0.028). When comparing discharged and deceased patients with DM, HbA1c and random blood glucose on admission were higher in the deceased patients ( p = 0.012 and 0.019, respectively). Regression analysis identified C-reactive protein ( p = 0.024), length of ICU stay ( p = 0.005), HbA1c ( p = 0.032), and Pneumonia Severity Index score ( p = 0.008) as significant predictors of mortality. DM is not only a comorbidity but also a factor that strongly influences the clinical course of CAP. Our study confirms the finding that patients with DM have a poor prognosis and high mortality during the course of CAP. It also showed that HbA1c and blood glucose levels at admission are associated with mortality. As pneumonia may be more severe in patients with high blood glucose and HbA1c on admission, it should be considered that these patients with DM may need to be treated earlier in the ICU.


  • Open Access

    Influenza Vaccination Among Patients Undergoing Treatment for Rheumatological Disorders: Awareness, Vaccination Rates, and Influencing Factors

    by Merve Sari Akyuz, Bülent Akyuz, Olgun Keskin, Ilhan Sezer

    Background/Aims: Patients with autoimmune inflammatory rheumatic diseases (AIIRDs) are particularly vulnerable to infections as a result of their underlying autoimmune conditions. This vulnerability is further exacerbated by immunosuppressive treatments and associated comorbidities. This study aims to evaluate influenza vaccination rates, hesitancy, and awareness among this patient population. Materials and Methods: This descriptive study included patients with AIIRD receiving treatment at rheumatology and pulmonary medicine outpatient clinics. Between January and April 2024, a questionnaire was administered to assess influenza vaccination rates, knowledge, and attitudes. Results: Of the patients, 34.3% had received at least 1 influenza vaccination, while only 13% were vaccinated annually. Additionally, 62.2% recognized that they were at risk for influenza infection due to their current illnesses and medications and believed that they should be vaccinated. However, 59.2% had not received any professional information about the influenza vaccine. Only 38.2% were aware that vaccination was available free of charge for their condition. Older age, prolonged medication use, extended duration since diagnosis, presence of comorbidities, awareness of influenza risk, and receiving information about vaccination were all significantly associated with having received at least 1 influenza vaccination. No statistical relationship was observed between the type of rheumatic disease and vaccination (P= .7803). Patients relying on social media, TV, or internet sources demonstrated greater vaccine hesitancy (P < .0001). Awareness of vaccination recommendations was significantly associated with medication type (P < .0001). Hesitancy was reported by 38.7% of all patients and 48% of unvaccinated patients, influenced by negative experiences during the COVID-19 vaccination process. Conclusion: Influenza vaccination coverage among patients with AIIRD remains suboptimal. Physician reminders during routine visits could enhance vaccination rates. Health authorities might consider implementing pop-up alerts in clinical systems to prompt physicians to recommend vaccination when prescribing immunosuppressive medications.


  • Open Access

    The Effect of Diabetes Mellitus and Glycemic Parameters on the Prognosis of COVID‐19 Disease

    by Işılay Kalan Sarı, Olgun Keskin, Ayşegül Seremet Keskin

    Studies show that coronavirus disease 2019 (COVID‐19) is more severe in people with diabetes. Although diabetes has been shown to be a risk factor for severe COVID‐19 disease, the relationship between fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c) with mortality and prognosis in COVID‐19 is still controversial. We designed this study to investigate the impact of diabetes on the prognosis of COVID‐19 and to show the relationship between FBG and HbA1c and COVID‐19 mortality. In this study, patients with COVID‐19 who were hospitalized in the COVID‐19 Ward of the Department of Chest Diseases and Intensive Care Unit of Antalya Research and Training Hospital between December 2019 and December 2021 were included. The patients’ demographic data, treatment and laboratory results, developing complications, and clinical outcomes were extracted from their electronic medical records. The mortality of patients with diabetes was significantly higher than that of patients without diabetes ( p : 0.0001). The duration of hospitalization, the development of complications, and the need for oxygen, antibiotics, and steroids were higher in patients with diabetes than in patients without diabetes ( p : 0.0001). C‐reactive protein, erythrocyte sedimentation rate, and fibrinogen, which are associated with poor prognosis in studies, were higher in patients with diabetes ( p : 0.0001). When comparing discharged and deceased patients with diabetes, HbA1c was higher in discharged patients and FBG was higher in deceased patients ( p : 0.003 and p : 0.030, respectively). Our study confirms the finding that COVID‐19 patients with diabetes have a poor prognosis and mortality. It also shows that FBG level is related to COVID‐19 mortality. Contrary to some studies, the low detection of HbA1c in deceased patients may indicate that initial blood glucose rather than glycemic control prior to infection, is associated with COVID‐19 mortality. The influence of HbA1c and FBG on COVID‐19 prognosis could be investigated in larger studies.

  • Open Access

    The Prognostic Role of Advanced Lung Cancer Inflammation Index in Patients with Idiopathic Pulmonary Fibrosis

    by Fulsen Bozkuş, Olgun Keskin

    Background: The advanced lung cancer inflammation index (ALI) is an innovative and thorough measure designed to assess both inflammation and nutritional status. It includes parameters such as albumin, body mass index (BMI), and the neutrophil-to-lymphocyte ratio (NLR). This research seeks to evaluate the prognosis of idiopathic pulmonary fibrosis (IPF) patients by integrating both inflammation and nutritional status, distinguishing it from conventional inflammation biomarkers. Methods: This study included 102 patients with IPF. Clinical data were extracted from the patients’ medical records. NLR and ALI scores were calculated based on data collected at the initiation of antifibrotic treatment using the following formulas: Neut/Lym for NLR and albumin × BMI/NLR for ALI. Results: ALI values were assessed across various IPF patient subgroups based on gender–age–physiology (GAP) stages (1, 2, and 3), forced vital capacity (FVC) (median split: p = 0.000 for all), but not for CCI categories (p = 0.233). Receiver operating characteristic (ROC) curve analysis revealed that ALI had a sensitivity of 63.6% and a specificity of 98.9% at a threshold of 11.2 (AUC = 0.945, 95% CI 0.892–0.998, p < 0.000). Conclusions: Our findings indicate that ALI levels are significantly associated with disease severity and mortality in IPF patients.


  • Open Access

    The Prognostic Role of Advanced Lung Inflammation Index in Patients with Idiopathic Pulmonary Fibrosis

    by Fulsen Bozkuş, Olgun Keskin

    Background: The Advanced Lung Cancer Inflammation Index (ALI) is a novel, comprehensive index that integrates inflammation and nutritional status, incorporating parameters such as albumin, body mass index (BMI), and the neutrophil-to-lymphocyte ratio (NLR). Unlike traditional inflammation biomarkers, this study aims to evaluate the prognosis of IPF patients by considering both inflammation and nutritional status. Method: A total of 102 patients with IPF were included in the study. Clinical data were obtained from the patients’ medical records. NLR and ALI score were calculated based on data collected at the initiation of antifibrotic treatment using the following formula: Neut/Lym and albumin × BMI / NLR. Results: IPF subject subgroups in terms of ALI based on gender–age–physiology (GAP) stages (1,2,3), FVC (median split, Conclusion: We determined that ALI levels are significantly associated with disease severity and mortality in patients with IPF.

  • Open Access

    Is Homocysteine Associated with the Prognosis of Covid-19 Pneumonia

    by Işılay Kalan Sarı, Olgun Keskin, Ayşegül Seremet Keskin, Hamit Yaşar Elli̇dağ, Orbay Harmandar

    Background/Aim. Coronavirus disease 2019 (COVID-19) is a life-threatening disease characterized by a prothrombotic state. Because homocysteine (Hcy) is a potential biomarker in thrombotic disease, this article aims to highlight the role of Hcy in the prognosis of COVID-19 pneumonia. Methods. This prospective study was conducted between April 2021 and December 2021 at the University of Health Sciences, Antalya Training and Research Hospital. 162 patients admitted to the emergency department for COVID-19 pneumonia and scheduled for hospitalization in the intensive care unit (ICU) or COVID-19 ward of the chest disease department were included in the study. Hcy levels and other necessary laboratory parameters were analyzed. Results. 134 patients were admitted to the COVID-19 ward and 28 to the ICU. Hcy levels were significantly higher in ICU patients than in ward patients ( p : 0.001 ). Of the 134 patients, 55 later required ICU treatment for various reasons and were transferred to the ICU. Hcy ( p : 0.010 ), ferritin ( p : 0.041 ), and LDH ( p : 0.010 ) were significantly higher in patients who were transferred to the ICU than in patients who remained in the ward. The Hcy level was associated with a poor prognosis. It was found that each unit increase in the Hcy level approximately doubled the risk of death in patients with COVID-19 (odds ratio: 1.753). Discussion. There are few studies examining the association between high Hcy levels and disease severity in COVID-19. Our study supports previous studies and shows the association between the need for intensive care and high Hcy levels. Conclusion. A high Hcy value is a helpful marker in determining the need for critical care on admission to the emergency department and a marker of poor prognosis in COVID-19 pneumonia.


  • Open Access

    Investigation of Effect of the Colistin Loading Dosage on the clinical, Microbiological, and Laboratory Results in Acinetobacter baumannii Ventilator‐Associated Pneumonia /Pneumonia

    by Ayşegül Seremet Keski̇n, Derya Seyman, Kübra Demir Önder, Filiz Kizilateş, Olgun Keski̇n

    Introduction and Objectives. The comparative efficacy of colistin with a loading dose (LD) and without LD remains unknown. We aimed at assessing the efficacy and safety of colistin with LD in patients with multidrug resistance (MDR) Acinetobacter baumannii ventilator‐associated pneumonia (VAP) or pneumonia, compared with colistin without LD. Materials and Methods. Adult patients administered colistin with and without LD for MDR Acinetobacter baumannii VAP/pneumonia in intensive care units (ICUs) in a tertiary teaching hospital between 1 January 2018 and 31 December 2019 were included in this retrospective cohort study. The primary endpoint was an assessment of clinical and microbiological success between treatment groups. Secondary endpoints included 14‐ and 30‐day mortality and development of nephrotoxicity. Results. A total of 101 patients were included (colistin with LD, n = 57; colistin without LD, n = 44). No significant difference in clinical success was observed between groups (73.7% versus 77.3%; p = 0.670). In patients receiving colistin with LD, the microbiological success rate increased from 65.9% to 71.9%, but there was no statistically significantly difference (p = 0.510). In terms of using combination therapies with carbapeneme and/or tigecycline, there was no significant difference between treatment groups (p = 0.30). The rates of 14‐ and 30‐day mortality were similar between groups. The colistin with LD group had a higher rate of nephrotoxicity compared to the other group (52.6% versus 20.5% p = 0.001). The clinical and microbiological response times were found significantly higher in the colistin with LD group (p = 0.001; p = 0.017). Conclusion. Colistin with LD was associated with a higher risk of nephrotoxicity and was not related to clinical success, microbiological success, and prolonged survival. Randomized comparative studies are needed to confirm the efficacy of LD colistin regimen on MDR Acinetobacter infection.


  • Open Access

    Evaluation of the Relationship between Serum 25-Hydroxyvitamin D Levels and Pulmonary Functions in Adult Asthma

    by Olgun Keski̇n, Nilgün Seremet Kürklü

    Aim: This study was aimed to determine the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and the pulmonary functions in adult asthma patients. Material and Methods: A total of 131 asthmatic patients’ general characteristics, asthma symptoms, pulmonary function test, asthma control test (ACT) scores, serum 25(OH)D levels, body weight, and height were recorded. Body mass indexes (BMIs) of the patients were calculated and World Health Organization criteria were used for the classification. Patients with serum 25(OH)D levels below 20 ng/mL were classified as having a deficiency, those with 21-29 ng/mL as having an insufficiency, and those with 30 ng/mL and above as having normal serum vitamin D levels. Results: The serum 25(OH)D levels of patients in the uncontrolled asthma group, according to the ACT score, were found to be lower than those of patients in the controlled group (p=0.002). It was determined that as the serum 25(OH)D levels of the patients increased, the ACT scores also increased significantly (r=0.280, p=0.001). Additionally it was found that each 1 ng/mL increase in 25(OH)D level was associated with an increase of 0.176 L in forced vital capacity (FVC). In addition it was determined that as the serum 25(OH)D levels increased, the patients’ FVCs also increased (OR=1.056, 95% CI=1.003-1.113, p=0.038). Although the change was not statistically significant (p=0.081), as serum 25(OH)D levels increased, the ACT scores also increased. Conclusion: Vitamin D insufficiency and deficiency were frequently found in adults with asthma and there was a relationship between vitamin D deficiency and pulmonary function.